Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 815 results for "hodgkin"

Maryland governor's diagnosis puts focus on non-Hodgkin lymphoma

Maryland's governor's diagnosis with non-Hodgkin lymphoma highlights current, and future, treatment advances against the disease. When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin ... City of Hope, 1 hour ago

286 images for hodgkin

Fresno Bee, 1 week ago
Medagadget.com, 1 day ago
NewsMax.com, 1 week ago
MDLinx, 16 hours ago
New Jersey 101.5, 1 day ago
Knox Village Soup, 1 day ago
TheStreet.com, 1 day ago
CNN, 1 week ago
GlobeNewswire, 1 day ago
One News Page United Kingdom, 2 days ago
Huffington Post

Gov. Larry Hogan's Stage 3 Non-Hodgkin Lymphoma Diagnosis, Explained

Maryland Gov. Larry Hogan (R) announced on Monday that he has been diagnosed with late stage 3 non-Hodgkin lymphoma , an aggressive form of lymph node cancer. Hogan, 59, sought medical attention after noticing a lump in his neck while shaving, and ...
 Huffington Post1 week ago Hogan's Type of Lymphoma Not Necessarily Incurable  Citybizlist1 week ago Md. Gov. Larry Hogan has non-Hodgkin's lymphoma. Even in late stages, it's often curable.  Washington Post1 week ago Forum Post: Non Hodgkins Follicular Lymphoma stage 4.  Macmillan Cancer Support1 week ago
[x]  

Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials [Hematologic Malignancy]

All authors: University Hospital of Cologne, Cologne, Germany. Corresponding author: Bastian von Tresckow, MD, Cologne University Hospital, Department of Internal Medicine I, 50924 Cologne, Germany; e-mail: bastian.von-tresckow{at}uk-koeln.de. ...
 Journal of Clinical Oncology1 week ago
NewsMax.com

Vivian Campbell's Hodgkin's Is Back; Def Leppard Star to Miss Shows

Vivian Campbell's cancer is back just two years after the Def Leppard guitarist fought and beat Hodgkin's lymphoma. Campbell posted on Facebook on Friday to tell his fans of his recent diagnosis and to announce he will be taking a leave of absence ...
 NewsMax.com1 week ago Vivian Campbell's Cancer Returns, Def Leppard Guitarist Continues His Fight Against Hodgkin's Lymphoma  Inquisitr1 week ago Vivian Campbell: Cancer Returns But Def Leppard Guitarist Vows To Resume Concerts Despite Hodgkin's Lymphoma [Video]  Fnews.com1 week ago
Med India

Physically Active People Face Lower Risk of Some Cancers Such as Colon, Breast Cancers

Performing vigorous physical activity over one's lifetime may lower the risk of non-Hodgkin lymphoma (NHL), claims a new study. "Our findings suggest that people who do vigorous physical activity may also have a lower risk for NHL," said study author Terry ...
 Med India1 month ago Intense physical exercise can lower lymphoma risk  Prokerala1 month ago Gastrointestinal tumours can lead to additional cancers  Jagran Post1 month ago Hepatitis C may increase cancer risk  Business Standard2 months ago
AllGov

Epidemiological studies found positive associations between exposure to DDT and non-Hodgkin lymphoma and liver cancer.

The insecticide lindane causescancer in humans and has been specifically linked to a form ofthe disease known as non-Hodgkin lymphoma, the World HealthOrganization's cancer research agency said on Tuesday. The International Agency for Research on ...
 Radio Pakistan1 week ago WHO agency says insecticides lindane and DDT linked to cancer  Reuters1 week ago 30.06 - Insecticide lindane causes cancer - LANCASTER  MyScience7 hours ago Insecticide lindane causes cancer  Lancaster University6 hours ago
[x]  
TheStreet.com

Juno Announces FDA Acceptance of Investigational New Drug Application for JCAR017 in Relapsed/Refractory B Cell Non-Hodgkin Lymphoma

 Securities Technology Monitor1 day ago JUNO THERAPEUTICS : Announces FDA Acceptance of Investigational New Drug Application for JCAR017 in Relapsed/Refractory B Cell Non-Hodgkin Lymphoma  4 Traders1 day ago Juno Therapeutics (JUNO) Announces FDA Acceptance Of Investigational New Drug Application For JCAR017 In Relapsed/Refractory B Cell Non-Hodgkin Lymphoma 6/29/2015  ClinicSpace1 day ago Juno Therapeutics Announces FDA Acceptance Of Investigational New Drug Application For JCAR017 In Relapsed/Refractory B Cell Non-Hodgkin Lymphoma  BioSpace1 day ago
[x]  

Investigator-Sponsored Trial Evaluating Biothera's Imprime PGG in Relapsed Indolent Non-Hodgkin Lymphoma

Biothera today announced that patient dosing has begun in an investigator-sponsored phase 2 trial of its investigational cancer immunotherapy, Imprime PGG, in combination with rituximab (Rituxan ® ) for relapsed indolent ...
 BioSpace1 week ago Biothera: Investigator-Sponsored Trial Evaluating Imprime PGG [Professional Services Close - Up]  Pharmacy Choice3 days ago
[x]  

NORDIC NANOVECTOR ASA : Highlights Updated Results of Ongoing Phase 1/2 Study with Betalutin in Relapsed CD37+ NHL Patients

Nordic Nanovector ASA reported updated results of its ongoing Phase 1/2 study with Betalutin in relapsed CD37+ non-Hodgkin lymphoma (NHL) patients. Data and analysis are presented in a poster (abstract 287) at the 13th International Conference on ...
 4 Traders6 days ago NORDIC NANOVECTOR ASA : Updated Results of Ongoing Phase 1/2 Study with Betalutin in Relapsed CD37+ Non-Hodgkin Lymphoma Patients  4 Traders1 week ago Nordic Nanovector: Updated Results of Ongoing Phase 1/2 Study with Betalutin in Relapsed CD37+ Non-Hodgkin Lymphoma Patients  Individual.com1 week ago Nordic Nanovector Highlights Updated Results of Ongoing Phase 1/2 Study with Betalutin in Relapsed CD37+ NHL Patients [Professional Services Close - Up]  Pharmacy Choice6 days ago
TheStreet.com

New Therapies to Drive Non-Hodgkin Lymphoma Treatment Market Value Beyond $9 Billion by 2020

/PRNewswire/ -- Promising drug pipeline and new entrants will widen targeted and immunotherapeutic treatment options, says GBI Research. Sponsored by: Analysis from business intelligence provider GBI Research - Non-Hodgkin Lymphoma Therapeutics in ...
 TickerTech.com1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hodgkin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less